v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current Assets    
Cash and cash equivalents $ 3,102,817 $ 1,117,028
Accounts receivable 252,242 317,808
Prepaid expenses 870,138 433,680
Other current assets 291,194 192,409
Total Current Assets 4,516,391 2,060,925
Property and equipment, net 3,771,181 4,027,849
Operating lease right-of-use assets 430,010 495,749
Intangible assets, net 318,901 316,704
Total Assets 9,036,483 6,901,227
Current Liabilities    
Accounts payable 3,718,795 2,918,768
Accrued liabilities 3,870,169 4,211,828
Deferred revenue 353,846 353,846
Management and directors' fees payable 68,783 80,939
Current portion of long-term debt 940,258 890,571
Current portion of finance lease liabilities 53,711 54,377
Current portion of operating lease liabilities 250,117 250,336
Current portion of grant repayable 114,825 117,093
Warrant liability 7,562 20,978
Derivative Liability 869,200 913,742
Current portion of convertible note payable, net 3,320,155 2,418,275
Total Current Liabilities 13,567,421 12,230,753
Long-term debt, net of current portion 6,351,763 5,818,354
Deferred revenue, net of current portion 21,225,421 21,938,462
Finance lease liabilities, net of current portion 298,384 317,859
Operating lease liabilities, net of current portion 208,660 276,558
Grant repayable, net of current portion 464,927 473,652
Convertible note payable, net of current portion 279,836 1,438,400
Total Long-Term Liabilities 28,828,991 30,263,285
Total Liabilities 42,396,412 42,494,038
Stockholders' Deficit    
Common Stock Authorized: 325,000,000 shares of common stock, at $0.001 par value per share Issued and outstanding: 7,930,612 shares and 6,288,988 shares, respectively 7,931 6,289
Additional paid-in capital 227,744,249 218,943,759
Accumulated other comprehensive income (160,764) (295,071)
Accumulated deficit (259,566,144) (252,901,370)
Total VolitionRx limited Stockholders' Deficit (31,974,728) (34,246,393)
Non-controlling interest (1,385,201) (1,346,418)
Total Stockholders' Deficit (33,359,929) (35,592,811)
Total Liabilities and Stockholders' Deficit $ 9,036,483 $ 6,901,227

Source

10-Q PDF
XBRL